Asia Pacific Heartstring Device And Enclosure Device Market
Market Size in USD Million
CAGR :
% 
USD
25.87 Million
USD
47.12 Million
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 25.87 Million |
 Market Size (Forecast Year) |
USD 47.12 Million |
 CAGR |
% |
| Major Markets Players |
|
Asia-Pacific Heartstring Device and Enclosure Device Market Segmentation, By Product Type (Enclose Device and Heartstring Device), Application (Coronary Artery Bypass Grafting (CABG), Aortic Anastomosis, Valve Surgery, and Other), Technology Type (Manual, Automated or Semi-Automated, and Others), End-User (Hospitals, Cardiac Surgery Centers, Academic & Research Institutes, and Others), Distribution Channel (Direct Tenders, Distributors & Dealers, Online Procurement Platforms, and Others) - Industry Trends and Forecast to 2032
Asia-Pacific Heartstring Device and Enclosure Device Market Size
- The Asia-Pacific Heartstring Device and Enclosure Device Market size was valued at USD 25.87 million in 2024 and is expected to reach USD 47.12 million by 2032, at a CAGR of 7.9% during the forecast period
- The expansion of the heartstring and enclosure device market is directly propelled by the increasing integration of smart home ecosystems and the widespread digitalization of commercial properties. This evolution is fueling strong demand for sophisticated, interconnected access control solutions.
- Additionally, shifting consumer expectations toward highly secure, intuitive, and seamless technologies are establishing heartstring and enclosure devices as the benchmark for modern access systems, thereby accelerating market-wide adoption and growth.
Asia-Pacific Heartstring Device and Enclosure Device Market Analysis
- Heartstring device and enclosure device refer to specialized components used across medical and technological applications to enhance safety, precision, and system integrity. The Heartstring device is primarily utilized in cardiovascular surgeries to temporarily seal blood vessels during procedures like coronary artery bypass grafting, minimizing the risk of complications such as embolism.
- Enclosure devices function as critical protective housings, safeguarding sensitive components within medical and smart technology systems from environmental hazards and unauthorized access. The synergy between heartstring and enclosure devices is therefore fundamental to ensuring procedural safety, optimizing device performance, and bolstering operational reliability across the healthcare and smart infrastructure sectors.
- Japan dominates and expected to dominate the Asia-Pacific Heartstring Device and Enclosure Device Market with the largest revenue share of 19.70% in 2025, primarily due to the presence of advanced healthcare infrastructure, high adoption of innovative surgical technologies, and increased investment in cardiac care solutions. Additionally, the region benefits from the presence of key market players, favorable reimbursement policies, and rising prevalence of cardiovascular diseases, all contributing to sustained market growth.
- Enclose device segment is expected to dominate the Asia-Pacific Heartstring Device and Enclosure Device Market with a market share of 65.28% in 2025, due to its critical role in facilitating safe, the enclosure device segment minimally invasive cardiac procedures. Its ability to ensure controlled vascular access and reduce procedural complications is driving widespread clinical adoption
Report Scope and Asia-Pacific Heartstring Device and Enclosure Device Market Segmentation
|
Attributes |
Heartstring Device and Enclosure Device Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
Asia-Pacific
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework |
Asia-Pacific Heartstring Device and Enclosure Device Market Trends
Growth potential in emerging healthcare regions
- Progress is accelerating through the expansion of healthcare infrastructure and the rising prevalence of cardiovascular disease in emerging regions
- Device manufacturers are increasingly collaborating with local hospitals and healthcare providers to introduce heartstring and enclosure systems tailored to the specific needs and resource constraints of these markets
- These partnerships focus on training healthcare professionals, improving procedural workflows, and facilitating access to advanced cardiac surgical technologies
For instance,
- In June 2024, a study published in Asian Cardiovascular & Thoracic Annals highlighted the significant strides made by the Cardiac Surgery Intersociety Alliance (CSIA) over five years in enhancing cardiac surgical care across emerging regions, including Asia and Africa. The study emphasized the importance of collaborative efforts in training, resource sharing, and capacity building to address the rising burden of cardiovascular diseases in these regions. By focusing on skill development and infrastructure improvement, the CSIA has played a pivotal role in expanding access to advanced cardiac surgical procedures, thereby tapping into the vast growth potential of these emerging healthcare markets
- In March 2022, a study published in the International Journal of Environmental Research and Public Health examined the implementation of telecardiology in rural areas across various countries. The research highlighted that telecardiology platforms, including remote monitoring and virtual consultations, have significantly improved access to cardiovascular care in underserved regions. Hospitals in these areas have partnered with telemedicine providers to train healthcare professionals, integrate digital health tools, and enhance patient outcomes. This collaboration has been crucial in addressing the rising demand for cardiac services in emerging healthcare regions
Emerging healthcare regions are rapidly upgrading their cardiac care capabilities through investments in infrastructure, training of their workforce, and strategic collaborations. These developments are opening significant opportunities for the adoption of advanced surgical tools like heartstring and enclosure devices.
Asia-Pacific Heartstring Device and Enclosure Device Market Dynamics
Driver
Rising Prevalence of Chronic Venous Disorders (CVDS) globally
- Chronic Venous Disorders (CVDs) — including varicose veins, chronic venous insufficiency, edema, and venous leg ulcers — are costly, debilitating, and typically progressive. Asia-Pacific risk factors like aging, obesity, sedentary behavior, and hereditary predisposition combine to increase this burden.
- Compression therapy is the frontline non-surgical treatment recommended by vascular health experts. Because CVDs often require lifelong management, demand for compression garments and devices continues to grow sustainably. This escalating demand underscores the need for ongoing innovation in compression technologies, providing more comfortable and effective solutions.
- For instance- In May 2023, according to the National Center for Biotechnology Information, a scoping review was conducted to assess the prevalence of chronic venous disease (CVD) among healthcare workers. This review, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, analyzed 15 publications. The findings revealed a mean CVD prevalence of 58.5% and a mean varicose vein prevalence of 22.1% among healthcare workers. These figures suggest an elevated prevalence of CVD in this group compared to the general population, highlighting the need for early diagnosis and preventative measures
- Furthermore, increased awareness and early diagnosis are crucial for slowing disease progression and improving patient quality of life. The economic impact of CVDs also underscores the importance of preventative measures and accessible, long-term management strategies.
- Ultimately, a multi-pronged approach involving lifestyle modifications, early intervention, and advanced compression therapies is essential to mitigate the rising Asia-Pacific burden of CVDs.
Opportunity
Advancements in heart String Device Technology and Usability
- Continuous innovation in off-pump CABG (Coronary Artery Bypass Grafting) systems, often exemplified by advancements like the Heartstring device, is significantly enhancing surgical accessibility and outcomes.
- These innovations focus on several key areas that directly benefit both the surgical team and the patient. Improvements in stabilizers enable a more precise and steadier surgical field on the beating heart, which is crucial for delicate anastomoses. Integrated imaging provides surgeons with enhanced visualization, improving accuracy and reducing complications
For instance,
- In October 2024, the National Center for Biotechnology Information highlighted that wearable devices are revolutionizing the management and diagnosis of Cardio vascular Disease (CVD). These cost-effective tools offer continuous, real-time monitoring of vital parameters, addressing limitations of traditional methods. The review discusses advancements in wearable technologies, categorized by galvanic contact, Photoplethysmography (PPG), and Radio Frequency (RF) waves, also emphasizing the role of AI in CVD diagnostics and future device perspectives
- Technological advancements are lowering technical barriers and enhancing the reproducibility of off-pump CABG procedures. These innovations support wider adoption by reducing surgeon training time, procedural risks, and hospital stays—aligning well with healthcare efficiency objectives.
By investing in R&D that improves usability and reliability, device makers can justify premium pricing and drive wider procurement by healthcare systems
Restraint/Challenge
Growing Preference for Minimally Invasive Cardiac Procedures
- Minimally invasive cardiac interventions are becoming the preferred approach over traditional open-heart surgery due to their alignment with critical clinical goals.
- Procedures like Off-Pump Coronary Artery Bypass (OPCAB), transcatheter closure of congenital defects, and percutaneous valve repair offer substantial benefits to both patients and healthcare systems.
- For instance- In December 2024, according to the National Center for Biotechnology Information, a comprehensive review was conducted to evaluate the utilization and outcomes of off-pump coronary artery bypass grafting (OPCAB). The study highlighted several concerns regarding the overuse of OPCAB, particularly in settings where surgeon experience and institutional volume are limited. It was noted that OPCAB is associated with higher rates of incomplete revascularization and inferior graft patency compared to on-pump CABG.
- These advanced techniques aim to significantly reduce patient trauma by utilizing smaller incisions or catheter-based methods, bypassing the need for a large chest incision. This less invasive approach results in shorter recovery periods, enabling patients to return to their daily lives more quickly with reduced pain and fewer complications.
- Ultimately, the adoption of these minimally invasive procedures also optimizes health system efficiency by potentially reducing hospital stays, lowering the risk of readmissions, and freeing up resources, demonstrating a clear advantage in modern cardiac care
Asia-Pacific Heartstring Device and Enclosure Device Market Scope
The market is segmented into five notable segments which are based on product type, application, technology type, end-user, and distribution channel.
- By Product Type
On the basis of product type, Asia-Pacific Heartstring Device and Enclosure Device Market is segmented into enclose device, and heartstring device. In 2025, the enclosure device segment is expected to dominate with 65.28% market share due to its critical role in facilitating safe, the enclosure device segment minimally invasive cardiac procedures. Its ability to ensure controlled vascular access and reduce procedural complications is driving widespread clinical adoption.
The enclose device segment is projected to grow at the highest CAGR of 8.0% during the forecast period. This rapid growth is fueled by the increasing adoption of these devices in complex, off-pump cardiac surgeries to improve patient outcomes. Continuous innovation in heartstring technology, leading to enhanced ease of use and greater reliability in creating secure anastomoses, is directly driving its expanding preference among cardiac surgeons.
- By Application
On the basis of application, the Asia-Pacific Heartstring Device and Enclosure Device Market is segmented into Coronary Artery Bypass Grafting (CABG), Aortic Anastomosis, Valve Surgery, and Other. Coronary Artery Bypass Grafting (CABG) is further segmented into Coronary Artery Bypass Grafting (CABG), aortic anastomosis, valve surgery, and other. In 2025, the Coronary Artery Bypass Grafting (CABG) segment is expected to dominate with 74.09% market share due to the growing burden of coronary artery disease and the increasing preference for off-pump surgical techniques. CABG procedures benefit significantly from heartstring and enclosure devices that enhance safety and reduce operative risks.
The Coronary Artery Bypass Grafting (CABG) segment is anticipated to exhibit the fastest growth, This growth is driven by the rising incidence of Coronary Artery in aging populations and the development of less invasive valve repair and replacement techniques. These advanced procedures demand precise and reliable tools like heartstring devices to ensure secure and effective outcomes, thereby accelerating adoption in this application.
- By Technology Type
On the basis of technology type, the Asia-Pacific Heartstring Device and Enclosure Device Market is segmented into manual, automated or semi-automated, and others. In 2025, the manual segment is expected to dominate with 65.31% market share due to its widespread clinical acceptance, cost-effectiveness, and ease of use in diverse surgical settings. Stapling systems and clip-based closure devices offer reliable performance with minimal training requirements, driving their continued preference.
The manual segment is poised to register the highest CAGR of 8.0% in the forecast period of 2025 to 2032. This growth is propelled by the increasing demand for enhanced surgical precision, reduced procedural times, and superior safety outcomes. The integration of automated technologies with robotic-assisted surgical platforms and the drive to minimize human error in complex cardiac procedures are key factors fueling its rapid market expansion.
- By End User
On the basis of end user, the Asia-Pacific Heartstring Device and Enclosure Device Market is segmented into hospitals, cardiac surgery centers, academic & research institutes, and others. In 2025, hospitals segment is expected to dominate with 63.49% market share due to the high volume of cardiac surgeries performed in Tier 1 and Tier 2 facilities and their access to advanced surgical infrastructure. These institutions also benefit from greater funding, skilled personnel, and integration of cutting-edge cardiovascular technologies.
Meanwhile, hospitals are projected to be the fastest-growing segment, with a CAGR of 8.2%. Their growth is attributed to a rising trend of procedural specialization, which allows these centers to achieve higher efficiency, superior patient outcomes, and quicker adoption of niche technologies. As healthcare shifts towards value-based models, these specialized centers are becoming increasingly preferred for complex cardiovascular interventions
- By Distribution Channel
On the basis of distribution channel, the Asia-Pacific Heartstring Device and Enclosure Device Market is segmented into direct tenders, distributors & dealers, online procurement platforms, and others. In 2025, the direct tenders segment is expected to dominate the market with 48.26% market share due to bulk purchasing by government-sponsored hospitals and large private hospital networks. This channel ensures cost efficiency, streamlined procurement, and faster access to advanced surgical devices.
The direct tenders segment is expected to record the highest CAGR over the forecast period. This trend is a direct result of the increasing digitalization of healthcare supply chains. These platforms offer greater price transparency, enhanced accessibility for a wider range of buyers (including smaller clinics and research institutes), and simplified logistics, making them an increasingly attractive channel for sourcing medical devices.
Asia-Pacific Heartstring Device and Enclosure Device Market Regional Analysis
- Asia-Pacific dominates and expected to dominate the Asia-Pacific Heartstring Device and Enclosure Device Market with the largest revenue share of 23.81% in 2025, primarily due to the presence of advanced healthcare infrastructure, high adoption of innovative surgical technologies, and increased investment in cardiac care solutions.
- Additionally, the region benefits from the presence of key market players, favorable reimbursement policies, and rising prevalence of cardiovascular diseases, all contributing to sustained market growth
Japan Asia-Pacific Heartstring Device and Enclosure Device Market Insight
Japan is witnessing strong market momentum in the medical device sector, driven by its advanced healthcare system, aging population, and demand for minimally invasive treatment solutions. The rising prevalence of cardiovascular diseases is boosting adoption of the Heartstring device, valued for its precision and ability to enhance surgical safety. Enclosure devices are also gaining traction, supported by stringent safety standards and the need for secure containment during procedures. Increasing hospital investments in innovative equipment and ongoing collaboration with global manufacturers are accelerating integration into clinical practice.
China Asia-Pacific Heartstring Device and Enclosure Device Market Insight
China held the largest revenue share in the Asia-Pacific medical device market in 2025, driven by a rapidly expanding healthcare infrastructure, rising disposable incomes, and growing awareness of advanced treatment options. With increasing prevalence of cardiovascular diseases and strong domestic manufacturing capabilities, the country is witnessing widespread adoption of Heartstring devices across leading hospitals and surgical centers. Enclosure devices are also seeing accelerated uptake, supported by stringent safety regulations and demand for enhanced procedural efficiency. Government investments in healthcare modernization and availability of cost-effective device options continue to fuel market growth.
Asia-Pacific Heartstring Device and Enclosure Device Market Share
The heartstring device and enclosure device industry is primarily led by well-established companies, including:
- Peters Surgical (France)
- Getinge (Sweden)
- KARL STORZ (Germany)
Latest Developments in Asia-Pacific Heartstring Device and Enclosure Device Market
- In July 2025, Getinge entered a strategic partnership with Zimmer Biomet to expand their offerings in the Ambulatory Surgical Center (ASC) sector. This collaboration combines Getinge’s OR infrastructure and sterilization solutions with Zimmer Biomet’s surgical technologies, enabling integrated, turnkey solutions for outpatient centers. The partnership enhances Getinge’s market reach, strengthens its ASC positioning, and supports growth in minimally invasive surgical care.
- In July 2024, Getinge announced the opening of its new Experience Center in India as part of its expansion strategy in Asia. This facility offers hands-on demonstrations of advanced surgical, intensive care, and sterile reprocessing solutions. The development enhances Getinge’s customer engagement, training capabilities, and strengthens its presence in a rapidly growing healthcare market.
- In October 2023, Getinge acquired Healthmark Industries Co. Inc. for approximately USD 320 million. Healthmark is a key provider of instrument care and infection control consumables. This acquisition strengthens Getinge’s position in sterile reprocessing, particularly in the U.S., while supporting Asia-Pacific expansion of Healthmark’s product offerings.
- In December 2024, Artivion, Inc. received FDA Humanitarian Device Exemption (HDE) approval for its AMDS Hybrid Prosthesis, marking a key regulatory milestone. This allows the early U.S. commercialization of AMDS for treating acute DeBakey Type I aortic dissections with malperfusion—representing roughly 40% of such cases. The device also holds Breakthrough and Humanitarian Use Designation due to its life-saving potential in a rare, high-risk condition. This development strengthens Artivion’s leadership in the structural heart and aortic surgery market, expands its clinical footprint, and paves the way for broader Premarket Approval (PMA) coverage in the future.
- In November 2023, Artivion announced the completion of patient enrollment in its PERSEVERE clinical trial for the AMDS Hybrid Prosthesis, intended for treating acute DeBakey Type I aortic dissections. The 93-patient, U.S.-based study will support a PMA (Premarket Approval) application to the FDA by 2025. This milestone strengthens Artivion’s position in the aortic and structural heart device market, targeting reduced mortality and complications in high-risk aortic surgery cases.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 COMPANY EVALUATION QUADRANT
4.3 IMPORT EXPORT SCENARIO
4.4 PRODUCTION CONSUMPTION ANALYSIS
4.5 BRAND OUTLOOK
4.5.1 BRAND POSITIONING AND CLINICAL TRUST
4.5.2 COMPETITIVE DIFFERENTIATION IN A TECHNOLOGICALLY EVOLVING MARKET
4.5.3 PHYSICIAN-CENTRIC APPROACH AND BRAND ADAPTABILITY
4.5.4 INSTITUTIONAL PROCUREMENT, BRAND EQUITY, AND FINANCIAL STRENGTH
4.5.5 DIGITAL INTEGRATION AND ASIA-PACIFIC BRAND VISIBILITY
4.6 CLIMATE CHANGE SCENARIO
4.6.1 ENVIRONMENTAL CONCERNS
4.6.2 INDUSTRY RESPONSE
4.6.3 GOVERNMENT’S ROLE
4.6.4 ANALYST RECOMMENDATIONS
4.7 CONSUMER BUYING BEHAVIOUR FOR HEARTSTRING DEVICE
4.7.1 CLINICAL EFFECTIVENESS AND SAFETY
4.7.2 COST AND VALUE-BASED PURCHASING
4.7.3 SURGEON PREFERENCES AND TRAINING SUPPORT
4.7.4 REGULATORY APPROVALS AND COMPLIANCE
4.7.5 BRAND REPUTATION AND VENDOR RELATIONSHIPS
4.8 CONSUMER BUYING BEHAVIOR FOR ENCLOSURE DEVICE
4.8.1 INNOVATION AND CLINICAL NEED
4.8.2 COST CONSIDERATIONS AND BUDGET IMPACT
4.8.3 TRUST IN MATERIAL SAFETY AND BIOCOMPATIBILITY
4.8.4 SURGEON EXPERTISE AND TRAINING REQUIREMENTS
4.8.5 REGULATORY ACCEPTANCE AND MARKET ADOPTION
4.9 SUPPLY CHAIN ANALYSIS
4.9.1 RAW MATERIAL PROCUREMENT AND SUPPLIER LANDSCAPE
4.9.2 MANUFACTURING AND ASSEMBLY OPERATIONS
4.9.3 REGULATORY COMPLIANCE AND QUALITY ASSURANCE
4.9.4 DISTRIBUTION, LOGISTICS, AND INVENTORY MANAGEMENT
4.9.5 AFTER-SALES SERVICES, TRAINING, AND LIFECYCLE MANAGEMENT
4.9.6 CONCLUSION
4.1 COST ANALYSIS BREAKDOWN
4.10.1 MANUFACTURING, ASSEMBLY, AND QUALITY CONTROL
4.10.2 R&D AND REGULATORY COMPLIANCE COSTS
4.10.3 PACKAGING, STERILIZATION, AND LOGISTICS
4.10.4 MARKETING, DISTRIBUTION, AND AFTER-SALES SUPPORT
4.10.5 CONCLUSION
4.11 INDUSTRY ECOSYSTEM ANALYSIS
4.11.1 PROMINENT COMPANIES
4.11.2 SMALL & MEDIUM SIZED COMPANIES
4.11.3 END USERS
4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.12.1 JOINT VENTURES
4.12.2 MERGERS AND ACQUISITIONS (M&A)
4.12.3 LICENSING AND PARTNERSHIPS
4.12.4 TECHNOLOGY COLLABORATIONS
4.12.5 COMPANY’S OVERVIEW
4.12.6 CONCLUSION
4.13 PRICING ANALYSIS – ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET
4.13.1 PREMIUM PRICING STRATEGY FOR SPECIALIZED CARDIAC DEVICES
4.13.2 PRICING BASED ON DEVICE TYPE AND APPLICATION
4.13.3 MANUFACTURER INFLUENCE ON PRICE POSITIONING
4.13.4 REGULATORY AND QUALITY COMPLIANCE COSTS
4.13.5 MARKET-SPECIFIC PRICING STRATEGIES
4.13.6 PROCUREMENT MODELS AND TENDERING SYSTEMS
4.13.7 INNOVATION AND ADDED FEATURES IMPACT ON PRICING
4.13.8 CONCLUSION
4.14 PROFIT MARGIN SCENARIO
4.14.1 GROSS PROFIT MARGIN
4.14.2 OPERATING PROFIT MARGIN ASSESSMENT
4.14.3 NET PROFIT MARGIN ANALYSIS
4.14.4 SCENARIO MODELING: BEST, BASE, AND WORST CASES
4.14.5 STRATEGIES TO OPTIMIZE PROFIT MARGINS
4.15 RAW MATERIAL COVERAGE
4.15.1 SILICONE ELASTOMER (HEARTSTRING DEVICE)
4.15.2 RADIOPAQUE POLYESTER (HEARTSTRING DEVICE)
4.15.3 STAINLESS STEEL (ENCLOSURE DEVICES)
4.15.4 NITINOL (ENCLOSURE DEVICES)
4.15.5 ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE (UHMWPE) (ENCLOSURE DEVICES)
4.16 TECHNOLOGICAL ADVANCEMENTS
4.16.1 ADVANCED ATRAUMATIC SEALING MECHANISMS
4.16.2 COMPACT, ERGONOMIC, AND USER-FRIENDLY DESIGNS
4.16.3 RAPID-DEPLOYMENT DELIVERY SYSTEMS
4.16.4 HYBRID BIOCOMPATIBLE MATERIALS FOR IMPROVED OUTCOMES
4.16.5 ENHANCED VISUALIZATION THROUGH IMAGING INTEGRATION
4.16.6 INTEGRATION WITH ROBOTIC AND MINIMALLY INVASIVE PLATFORMS
4.16.7 DATA-DRIVEN FEEDBACK AND DIGITAL INTEGRATION
4.17 VALUE CHAIN ANALYSIS
4.17.1 RAW MATERIAL PROCUREMENT
4.17.2 RESEARCH & DEVELOPMENT (R&D)
4.17.3 PRODUCT DESIGN AND PROTOTYPING
4.17.4 MANUFACTURING AND ASSEMBLY
4.17.5 REGULATORY APPROVALS AND QUALITY ASSURANCE
4.17.6 DISTRIBUTION AND LOGISTICS
4.17.7 MARKETING AND SALES
4.17.8 TRAINING AND TECHNICAL SUPPORT
4.17.9 AFTER-SALES SERVICE AND FEEDBACK INTEGRATION
4.18 VENDOR SELECTION CRITERIA
4.18.1 TECHNOLOGICAL CAPABILITIES AND INNOVATION PIPELINE
4.18.2 REGULATORY COMPLIANCE AND QUALITY CERTIFICATIONS
4.18.3 MANUFACTURING INFRASTRUCTURE AND SUPPLY CHAIN STRENGTH
4.18.4 CLINICAL SUPPORT, CUSTOMIZATION, AND AFTER-SALES SERVICE
4.18.5 MARKET REPUTATION, CUSTOMER BASE, AND FINANCIAL STABILITY
4.19 TARIFFS AND THEIR IMPACT ON MARKET
4.19.1 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS
4.19.2 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE
4.19.3 VENDOR SELECTION CRITERIA DYNAMICS
4.19.4 IMPACT ON SUPPLY CHAIN
4.19.4.1 COMPONENT PROCUREMENT
4.19.4.2 MANUFACTURING AND PRODUCTION
4.19.4.3 LOGISTICS AND DISTRIBUTION
4.19.4.4 PRICE PITCHING AND POSITION OF MARKET
4.19.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
4.19.5.1 SUPPLY CHAIN OPTIMIZATION
4.19.5.2 REGIONAL MANUFACTURING AND NEARSHORING
4.19.6 IMPACT ON PRICES
4.19.7 REGULATORY INCLINATION
4.19.7.1 INDUSTRY LOBBYING FOR EXEMPTIONS
4.19.7.2 LONG-TERM POLICY RESPONSE
4.19.7.3 TRADE AGREEMENTS & REGIONAL ALIGNMENT
4.19.8 CONCLUSION
5 REGULATORY FRAMEWORK
5.1 PRODUCT CODES
5.2 CERTIFIED STANDARDS
5.3 SAFETY STANDARDS
5.3.1 MATERIAL HANDLING & STORAGE
5.3.2 TRANSPORT & PRECAUTIONS
5.3.3 HAZARD IDENTIFICATION
5.4 PRODUCT CODES
5.5 CERTIFIED STANDARDS
5.6 SAFETY STANDARDS
5.6.1 MATERIAL HANDLING & STORAGE
5.6.2 HAZARD IDENTIFICATION
5.7 PRODUCT CODES (ASIA PACIFIC CLASSIFICATION)
5.8 CERTIFIED STANDARDS
5.9 SAFETY STANDARDS
5.9.1 MATERIAL HANDLING & STORAGE
5.9.2 TRANSPORT & PRECAUTIONS
5.9.3 HAZARD IDENTIFICATION
5.1 PRODUCT CODES (DEVICE CLASSIFICATION)
5.11 CERTIFIED STANDARDS
5.12 SAFETY STANDARDS
5.12.1 MATERIAL HANDLING & STORAGE
5.12.2 TRANSPORT & PRECAUTIONS
5.12.3 HAZARD IDENTIFICATION
5.13 PRODUCT CODES
5.14 CERTIFIED STANDARDS
5.15 SAFETY STANDARDS
5.15.1 MATERIAL HANDLING & STORAGE
5.15.2 TRANSPORT & PRECAUTIONS
5.15.3 HAZARD IDENTIFICATION
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS (CVDS) GLOBALLY
6.1.2 RISING PREVALENCE OF CARDIOVASCULAR DISEASES (CVDS) GLOBALLY
6.1.3 INCREASING ADOPTION OF OFF-PUMP CABG (“HEART STRING”) TECHNIQUES
6.1.4 ADVANCEMENTS IN HEART STRING DEVICE TECHNOLOGY AND USABILITY
6.2 RESTRAINTS
6.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE CARDIAC PROCEDURES
6.2.2 HIGH COST OF DEVICES & LIMITED REIMBURSEMENT IN DEVELOPING MARKETS
6.3 OPPORTUNITIES
6.3.1 GROWTH POTENTIAL IN EMERGING HEALTHCARE REGIONS
6.3.2 INTEGRATION OF AI FOR SURGICAL PRECISION IMPROVEMENT
6.3.3 GROWTH OF TELECARDIOLOGY AND REMOTE PROCEDURE PLANNING
6.4 CHALLENGES
6.4.1 INCONSISTENT ADOPTION ACROSS FACILITIES
6.4.2 RISK OF COMPLICATIONS WITH IMPROPER DEVICE USAGE
7 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 ENCLOSE DEVICE
7.3 HEARTSTRING DEVICE
8 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE
8.1 OVERVIEW
8.2 MANUAL
8.3 AUTOMATED OR SEMI-AUTOMATED
8.4 OTHERS
9 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CORONARY ARTERY BYPASS GRAFTING (CABG)
9.3 AORTIC ANASTOMOSIS
9.4 VALVE SURGERY
9.5 OTHER
10 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CARDIAC SURGERY CENTERS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 DISTRIBUTORS & DEALERS
11.4 ONLINE PROCUREMENT PLATFORMS
11.5 OTHERS
12 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 JAPAN
12.1.2 CHINA
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 THAILAND
12.1.7 SINGAPORE
12.1.8 INDONESIA
12.1.9 MALAYSIA
12.1.10 PHILIPPINES
12.1.11 TAIWAN
12.1.12 HONG KONG
12.1.13 NEW ZEALAND
12.1.14 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 GETINGE
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS/NEWS
15.2 PETERS SURGICAL
15.2.1 COMPANY SNAPSHOT
15.2.2 COMPANY SHARE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 KARL STORZ
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 ARTIVION, INC
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 CARDINAL HEALTH
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 FUMEDICA MEDIZINTECHNIK GMBH
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 HENRY SCHEIN, INC
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 JOHNSON & JOHNSON
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 KLS MARTIN GROUP
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 MEDLINE INDUSTRIES, LP
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 MEDTRONIC
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 OWENS & MINOR, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 SANTAIR AE
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 SONTEC INSTRUMENTS, INC.
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 TELEFLEX INCORPORATED
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 TERUMO CORPORATION
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENT
15.17 UNIPHAR GROUP PLC
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 SERVICE PORTFOLIO
15.17.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 STRATEGIC INNOVATION TYPES AND THEIR IMPACT
TABLE 2 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC HEARTSTRING DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC AUTOMATED OR SEMI-AUTOMATED IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC OTHER IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC DISTRIBUTORS & DEALER IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC ONLINE PROCUREMENT PLATFORMS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY COUNTRY, 2018-2032 (USD)
TABLE 36 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 52 JAPAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 JAPAN ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 54 JAPAN ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 JAPAN CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 56 JAPAN AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 JAPAN VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 JAPAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 59 JAPAN MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 JAPAN OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 JAPAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 62 JAPAN HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 JAPAN CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 JAPAN ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 JAPAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 66 JAPAN DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 JAPAN DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 68 CHINA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 CHINA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 CHINA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 71 CHINA CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 CHINA AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 CHINA VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 74 CHINA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 CHINA MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 CHINA OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 77 CHINA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 78 CHINA HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 CHINA CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 CHINA ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 CHINA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 82 CHINA DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 CHINA DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 84 INDIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 INDIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 INDIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 INDIA CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 INDIA AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 INDIA VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 INDIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 INDIA MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 INDIA OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 INDIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 94 INDIA HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 INDIA CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 INDIA ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 INDIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 98 INDIA DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 INDIA DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 100 SOUTH KOREA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 101 SOUTH KOREA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 SOUTH KOREA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 SOUTH KOREA CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 SOUTH KOREA AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 SOUTH KOREA VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 SOUTH KOREA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 SOUTH KOREA MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 SOUTH KOREA OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 SOUTH KOREA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 110 SOUTH KOREA HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 SOUTH KOREA CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 SOUTH KOREA ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 SOUTH KOREA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 114 SOUTH KOREA DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 SOUTH KOREA DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 116 AUSTRALIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 AUSTRALIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 AUSTRALIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 119 AUSTRALIA CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 AUSTRALIA AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 AUSTRALIA VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 AUSTRALIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 123 AUSTRALIA MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 AUSTRALIA OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 AUSTRALIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 126 AUSTRALIA HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 127 AUSTRALIA CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 AUSTRALIA ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 AUSTRALIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 130 AUSTRALIA DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 AUSTRALIA DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 132 THAILAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 THAILAND ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 THAILAND ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 THAILAND CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 THAILAND AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 THAILAND VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 THAILAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 THAILAND MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 THAILAND OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 THAILAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 142 THAILAND HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 THAILAND CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 THAILAND ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 THAILAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 146 THAILAND DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 THAILAND DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 148 SINGAPORE HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 SINGAPORE ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 SINGAPORE ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 151 SINGAPORE CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 SINGAPORE AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SINGAPORE VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 SINGAPORE HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 SINGAPORE MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 156 SINGAPORE OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 SINGAPORE HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 158 SINGAPORE HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 SINGAPORE CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 160 SINGAPORE ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 SINGAPORE HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 162 SINGAPORE DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 SINGAPORE DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 164 INDONESIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 165 INDONESIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 166 INDONESIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 INDONESIA CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 168 INDONESIA AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 INDONESIA VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 INDONESIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 INDONESIA MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 172 INDONESIA OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 INDONESIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 174 INDONESIA HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 175 INDONESIA CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 INDONESIA ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 INDONESIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 178 INDONESIA DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 INDONESIA DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 180 MALAYSIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 MALAYSIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 MALAYSIA ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 MALAYSIA CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 MALAYSIA AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 185 MALAYSIA VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 MALAYSIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 MALAYSIA MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 MALAYSIA OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 189 MALAYSIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 190 MALAYSIA HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 191 MALAYSIA CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 MALAYSIA ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 MALAYSIA HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 194 MALAYSIA DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 MALAYSIA DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 196 PHILIPPINES HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 PHILIPPINES ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 PHILIPPINES ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 PHILIPPINES CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 PHILIPPINES AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 201 PHILIPPINES VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 PHILIPPINES HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 PHILIPPINES MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 204 PHILIPPINES OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 PHILIPPINES HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 206 PHILIPPINES HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 207 PHILIPPINES CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 PHILIPPINES ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 209 PHILIPPINES HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 210 PHILIPPINES DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 PHILIPPINES DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 212 TAIWAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 TAIWAN ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 TAIWAN ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 TAIWAN CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 TAIWAN AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 TAIWAN VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 TAIWAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 TAIWAN MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 TAIWAN OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 TAIWAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 222 TAIWAN HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 TAIWAN CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 224 TAIWAN ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 TAIWAN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 226 TAIWAN DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 TAIWAN DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 228 HONG KONG HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 HONG KONG ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 HONG KONG ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 231 HONG KONG CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 HONG KONG AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 233 HONG KONG VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 HONG KONG HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 235 HONG KONG MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 236 HONG KONG OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 HONG KONG HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 238 HONG KONG HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 HONG KONG CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 HONG KONG ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 HONG KONG HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 242 HONG KONG DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 HONG KONG DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 244 NEW ZEALAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 245 NEW ZEALAND ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 NEW ZEALAND ENCLOSE DEVICE IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 247 NEW ZEALAND CORONARY ARTERY BYPASS GRAFTING (CABG) IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 NEW ZEALAND AORTIC ANASTOMOSIS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 NEW ZEALAND VALVE SURGERY IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 NEW ZEALAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TECHNOLOGY TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 NEW ZEALAND MANUAL IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 NEW ZEALAND OTHERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 253 NEW ZEALAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY END-USER, 2018-2032 (USD THOUSAND)
TABLE 254 NEW ZEALAND HOSPITALS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 NEW ZEALAND CARDIAC SURGERY CENTERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 256 NEW ZEALAND ACADEMIC & RESEARCH INSTITUTES IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 257 NEW ZEALAND HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 258 NEW ZEALAND DIRECT TENDERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 259 NEW ZEALAND DISTRIBUTORS & DEALERS IN HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 260 REST OF ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
List of Figure
FIGURE 1 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: ASIA-PACIFIC VS REGIONAL ANALYSIS
FIGURE 5 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET, BY PRODUCT TYPE (2024)
FIGURE 14 RISING PREVALENCE OF CARDIOVASCULAR DISEASES (CVDS) GLOBALLY EXPECTED TO DRIVE THE ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET IN 2025 & 2032
FIGURE 16 IMPORT EXPORT SCENARIO (USD THOUSAND)
FIGURE 17 PRODUCTION CONSUMPTION ANALYSIS: ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET
FIGURE 18 DROC ANALYSIS
FIGURE 19 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY PRODUCT TYPE, 2024
FIGURE 20 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 21 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY PRODUCT TYPE, CAGR (2025- 2032)
FIGURE 22 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY TECHNOLOGY TYPE, 2024
FIGURE 24 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY TECHNOLOGY TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 25 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY TECHNOLOGY TYPE, CAGR (2025- 2032)
FIGURE 26 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY TECHNOLOGY TYPE, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY APPLICATION, 2024
FIGURE 28 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 29 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY APPLICATION, CAGR (2025- 2032)
FIGURE 30 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY END USER, 2024
FIGURE 32 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 33 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY END USER, CAGR (2025- 2032)
FIGURE 34 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 36 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 37 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)
FIGURE 38 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: SNAPSHOT (2024)
FIGURE 40 ASIA-PACIFIC HEARTSTRING DEVICE AND ENCLOSURE DEVICE MARKET: COMPANY SHARE 2024 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
